Literature DB >> 24532938

Capecitabine induced Hand-Foot Syndrome: Report of two cases.

Sunil Sanghi1, R S Grewal2, Biju Vasudevan1, A Nagure3.   

Abstract

Entities:  

Keywords:  5-Fluorouracil; Capecitabine; Hand–Foot Syndrome

Year:  2012        PMID： 24532938      PMCID： PMC3862781          DOI： 10.1016/j.mjafi.2012.01.009

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  8 in total

1.  Identifying and treating fluoropyrimidine-associated hand-and-foot syndrome in white and non-white patients.

Authors:  Muhammad Wasif Saif; Aymen A Elfiky
Journal:  J Support Oncol       Date:  2007 Jul-Aug

2.  Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion.

Authors:  C J Fabian; R Molina; M Slavik; S Dahlberg; S Giri; R Stephens
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

Review 3.  Management of hand-foot syndrome induced by capecitabine.

Authors:  Sarah M Gressett; Brad L Stanford; Fred Hardwicke
Journal:  J Oncol Pharm Pract       Date:  2006-09       Impact factor: 1.809

4.  Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.

Authors:  J J Lokich; C Moore
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

Review 5.  Capecitabine: nursing implications of a new oral chemotherapeutic agent.

Authors:  M E Mrozek-Orlowski; D K Frye; H M Sanborn
Journal:  Oncol Nurs Forum       Date:  1999-05       Impact factor: 2.172

6.  Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapies.

Authors:  Amy S Clark; Linda T Vahdat
Journal:  Support Cancer Ther       Date:  2004-07-01

Review 7.  Serious hand-and-foot syndrome in black patients treated with capecitabine: report of 3 cases and review of the literature.

Authors:  Parthas Narasimhan; Sudha Narasimhan; Ibrahim F Hitti; Mercea Rachita
Journal:  Cutis       Date:  2004-02

8.  Hand-foot syndrome due to capecitabine.

Authors:  Amar Surjushe; Resham Vasani; Sudhir Medhekar; Minal Thakre; D G Saple
Journal:  Indian J Dermatol       Date:  2008-01       Impact factor: 1.494
  8 in total
  3 in total

1.  Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.

Authors:  Kalaivani Murugan; Vikas Ostwal; Maria Deo Carvalho; Anita D'souza; Meera S Achrekar; Shrinivasan Govindarajan; Sudeep Gupta
Journal:  Support Care Cancer       Date:  2015-12-30       Impact factor: 3.603

2.  Hyperpigmentation with Capecitabine: Part of Hand-Foot Syndrome or a Separate Entity?

Authors:  Jennifer Caprez; Umar Rahim; Amna Ansari; Muhammad Uzair Lodhi; Mustafa Rahim
Journal:  Cureus       Date:  2018-03-30

3.  Capecitabine-Associated Loss of Fingerprints: A Case Report of a 62-Year-Old Man With Colorectal Cancer Suffering From Capecitabine-Induced Adermatoglyphia.

Authors:  Tasneem Dawood; Muhammad Nauman Zahir; Muhammad Afzal; Yasmin Abdul Rashid
Journal:  Cureus       Date:  2021-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.